Cargando…

Changes in Serum Neutralizing Antibodies Levels During Convalescence of COVID-19 Patients

Detection of serum-specific SARS-CoV-2 antibody has become a complementary means for the identification of coronavirus disease 2019 (COVID-19). As we already know, the neutralizing antibody titers in patients with COVID-19 decrease during the course of time after convalescence, whereas the duration...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Qing-Qing, Gong, Lei, Wu, Xiao-Min, Feng, Ya-Ting, Luo, Wan-Rong, Zhou, Xue, Yuan, Yuan, Yu, Jun-Ling, He, Lan, Wang, Peng, Ge, Ying-Lu, Hou, Sai, Li, Wei-Wei, Sun, Yong, Wu, Jia-Bing, Su, Bin, Pan, Hai-Feng, He, Jun, Liu, Zhi-Rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879838/ https://www.ncbi.nlm.nih.gov/pubmed/35223924 http://dx.doi.org/10.3389/fmed.2022.829273

Ejemplares similares

Neutralizing antibodies in convalescent patients
por: Uhl, Lion F. K., et al.
Publicado: (2020)

The Epidemiological Pattern and Co-infection of Influenza A and B by Surveillance Network From 2009 to 2014 in Anhui Province, China
por: He, Jun, et al.
Publicado: (2022)

Neutralization of five SARS-CoV-2 variants of concern by convalescent and BBIBP-CorV vaccinee serum
por: Zhu, Yuqi, et al.
Publicado: (2022)

Progress of the COVID-19: Persistence, Effectiveness, and Immune Escape of the Neutralizing Antibody in Convalescent Serum
por: Liang, Dan, et al.
Publicado: (2022)

Neutralization of SARS-CoV-2 variants by convalescent and vaccinated serum
por: Bates, Timothy A., et al.
Publicado: (2021)

Neutralizing antibodies against SARS-CoV-2 virus after vaccination in patients with neurofibromatosis type 1
por: Ruan, Qiao-ling, et al.
Publicado: (2023)

Novel coronavirus mutations: Vaccine development and challenges
por: Luo, Wan-Rong, et al.
Publicado: (2022)

Identification of broad neutralizing antibodies against Omicron subvariants from COVID-19 convalescents and vaccine recipients
por: Chen, Jun, et al.
Publicado: (2023)

Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum
por: Uriu, Keiya, et al.
Publicado: (2021)

Successful recovery of COVID-19-associated recurrent diarrhea and gastrointestinal hemorrhage using convalescent plasma
por: Zhang, Li-Bo, et al.
Publicado: (2020)

Replication in the presence of dengue convalescent serum impacts Zika virus neutralization sensitivity and fitness
por: Marano, Jeffrey M., et al.
Publicado: (2023)

Immune memory in convalescent patients with asymptomatic or mild COVID-19
por: Long, Quan-Xin, et al.
Publicado: (2021)

A COMPARISON BETWEEN CONVALESCENT SERUM AND NON-CONVALESCENT SERUM IN POLIOMYELITIS
por: Brodie, Maurice
Publicado: (1932)

SARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum, but evades most convalescent serum and therapeutic antibodies
por: Lusvarghi, Sabrina, et al.
Publicado: (2022)

Comparing SARS-CoV-2 neutralizing antibody levels in convalescent unvaccinated, convalescent vaccinated, and naive vaccinated subjects
por: Dulipsingh, Latha, et al.
Publicado: (2023)

Rational identification of potent and broad sarbecovirus-neutralizing antibody cocktails from SARS convalescents
por: Cao, Yunlong, et al.
Publicado: (2022)

Assessment of Serum Tumor Markers for Predicting Ocular Metastasis in Lung Adenocarcinoma: A Retrospective Study
por: Shi, Wen-Qing, et al.
Publicado: (2020)

Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum
por: Liu, Chang, et al.
Publicado: (2021)

SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons
por: Rössler, Annika, et al.
Publicado: (2022)

Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor associates with distinct epitopes on the RBD
por: Zhou, Yunjiao, et al.
Publicado: (2021)

Reduced neutralization of SARS-CoV-2 B.1.617 variant by convalescent and vaccinated sera
por: Hu, Jie, et al.
Publicado: (2021)

Crucial Mutations of Spike Protein on SARS-CoV-2 Evolved to Variant Strains Escaping Neutralization of Convalescent Plasmas and RBD-Specific Monoclonal Antibodies
por: Ding, Chengchao, et al.
Publicado: (2021)

Broadly neutralizing antibodies derived from the earliest COVID-19 convalescents protect mice from SARS-CoV-2 variants challenge
por: Liu, Qianyun, et al.
Publicado: (2023)

Neutralization of SARS-CoV-2 variants by convalescent and BNT162b2 vaccinated serum
por: Bates, Timothy A., et al.
Publicado: (2021)

Scarlatina Treated with Convalescent Serum
Publicado: (1914)

Drastic decline in sera neutralization against SARS-CoV-2 Omicron variant in Wuhan COVID-19 convalescents
por: Ma, Chengbao, et al.
Publicado: (2022)

Sex disparities and neutralizing antibody durability to SARS-CoV-2 infection in convalescent individuals
por: Markmann, Alena J., et al.
Publicado: (2021)

Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals
por: Markmann, Alena J., et al.
Publicado: (2021)

Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients
por: Li, Yang, et al.
Publicado: (2020)

The Adenosine Deaminase Gene Polymorphism Is Associated with Chronic Heart Failure Risk in Chinese
por: He, Hai-Rong, et al.
Publicado: (2014)

SARS-CoV-2 omicron BA.1.1 is highly resistant to antibody neutralization of convalescent serum from the origin strain
por: Li, Jianhua, et al.
Publicado: (2023)

Longitudinal Serological Analysis and Neutralizing Antibody Levels in Coronavirus Disease 2019 Convalescent Patients
por: Muecksch, Frauke, et al.
Publicado: (2020)

Impact of pathogen reduction technology on neutralizing antibody titer in COVID-19 convalescent plasma
por: Franchini, Massimo, et al.
Publicado: (2022)

Simple prediction of COVID-19 convalescent plasma units with high levels of neutralization antibodies
por: Jazbec, Katerina, et al.
Publicado: (2023)

Loss of HRD functional phenotype impedes immunotherapy and can be reversed by HDAC inhibitor in ovarian cancer
por: Yang, Dong, et al.
Publicado: (2023)

Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies
por: Cheng, Lin, et al.
Publicado: (2021)

Impact of vaccination on kinetics of neutralizing antibodies against SARS-CoV-2 by serum live neutralization test based on a prospective cohort
por: Zhu, Liguo, et al.
Publicado: (2023)

Screening of potent neutralizing antibodies against SARS-CoV-2 using convalescent patients-derived phage-display libraries
por: Pan, Yongbing, et al.
Publicado: (2021)

A 1-year longitudinal study on COVID-19 convalescents reveals persistence of anti-SARS-CoV-2 humoral and cellular immunity
por: Li, Yang, et al.
Publicado: (2022)

Clinical characteristics and impacts of traditional Chinese medicine treatment on the convalescents of COVID-19
por: An, Ya-Wen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lbd3l8puj7c95qdjmgplmp6jkt